This paper proposes a segmentation-free radiomics method to classify malignant and benign breast tumors with shear-wave elastography (SWE) data. The method is targeted to integrate the advantage of both SWE in providing important elastic with morphology information and convolutional neural network (CNN) in automatic feature extraction and accurate classification. Compared to traditional methods, the proposed method is designed to directly extract features from the dataset without the pre-requisite of segmentation and manual operation. This can keep the peri-tumor information which is lost by segmentation-based methods. With the proposed model trained on 205 cases (70 from malignant breast patients and 135 from benign breast patients respectively), an accuracy of 95.79%, a sensitivity of 96.23% and a specificity of 95.65% was obtained for the final test. The superior performances compared to the existing state-of-the-art methods and its automatic nature both demonstrate that the proposed method has a great potential to be applied to clinical computer-aided diagnosis of breast cancer.

Objectives: The objective of our project is to explore a noninvasive radiomics model based on magnetic resonance imaging (MRI) that could recognize the expression of vascular endothelial growth factor (VEGF) in hepatocellular carcinoma before operation.Methods: 202 patients with proven single HCC were enlisted and stochastically distributed into a training set (n = 142) and a test set (n = 60). Arterial phase, portal venous phase, balanced phase, delayed phase, and hepatobiliary phase images were used to radiomics features extraction. We retrieved 1906 radiomic features from each phase of every participant’s MRI images. The F-test was applied to choose the crucial features. A logistic regression model was adopted to generate a radiomics signature. By combining independent risk indicators from the fusion radiomics signature and clinico-radiological features, we developed a multivariable logistic regression model that could predict the VEGF status preoperatively through calculating the area under the curve (AUC).Results: The entire group comprised 108 VEGF-positive individuals and 94 VEGF-negative patients. AUCs of 0.892 (95% confidence interval [CI]: 0.839 - 0.945) in the training dataset and 0.800 (95% CI: 0.682 - 0.918) in the test dataset were achieved by utilizing radiomics features from two phase images (8 features from the portal venous phase and 5 features from the hepatobiliary phase). Furthermore, the nomogram relying on a combined model that included the clinical factors α-fetoprotein (AFP), irregular tumor margin, and the fusion radiomics signature performed well in both the training (AUC = 0.936, 95% CI: 0.898-0.974) and test (AUC = 0.836, 95% CI: 0.728-0.944) datasets.Conclusions: The combined model acquired from two phase (portal venous and hepatobiliary phase) pictures of gadolinium-ethoxybenzyl-diethylenetriamine-pentaacetic acid (Gd-EOB-DTPA)-enhanced MRI could be considered as a credible prognostic marker for the level of VEGF in HCC.

To explore the application of multiparametric MRI-based radiomic nomogram for assessing HER-2 2+ status of breast cancer (BC). Patients with pathology-proven HER-2 2+ invasive BC, who underwent preoperative MRI were divided into training (72 patients, 21 HER-2-positive and 51 HER-2-negative) and validation (32 patients, 9 HER-2-positive and 23 HER-2-negative) sets by randomization. All were classified as HER-2 2+ FISH-positive (HER-2-positive) or -negative (HER-2-negative) according to IHC and FISH. The 3D VOI was drawn on MR images by two radiologists. ADC, T2WI, and DCE images were analyzed separately to extract features (n = 1906). L1 regularization, F-test, and other methods were used to reduce dimensionality. Binary radiomics prediction models using features from single or combined imaging sequences were constructed using logistic regression (LR) classifier then and validated on a validation dataset. To build a radiomics nomogram, multivariate LR analysis was conducted to identify independent indicators. An evaluation of the model's predictive efficacy was made using AUC. On the basis of combined ADC, T2WI, and DCE images, ten radiomic features were extracted following feature dimensionality reduction. There was superior diagnostic efficiency of radiomic signature using all three sequences compared to either one or two sequences (AUC for training group: 0.883; AUC for validation group: 0.816). Based on multivariate LR analysis, radiomic signature and peritumoral edema were independent predictors for identifying HER-2 2 +. In both training and validation datasets, nomograms combining peritumoral edema and radiomics signature demonstrated an effective discrimination (AUCs were respectively 0.966 and 0. 884). The nomogram that incorporated peritumoral edema and multiparametric MRI-based radiomic signature can be used to effectively predict the HER-2 2+ status of BC.

Purpose: Assessment of the stability of intracranial aneurysms is important in the clinic but remains challenging. The aim of this study was to construct a deep learning model (DLM) to identify unstable aneurysms on computed tomography angiography (CTA) images. Methods: The clinical data of 1041 patients with 1227 aneurysms were retrospectively analyzed from August 2011 to May 2021. Patients with aneurysms were divided into unstable (ruptured, evolving and symptomatic aneurysms) and stable (fortuitous, nonevolving and asymptomatic aneurysms) groups and randomly divided into training (833 patients with 991 aneurysms) and internal validation (208 patients with 236 aneurysms) sets. One hundred and ninety-seven patients with 229 aneurysms from another hospital were included in the external validation set. Six models based on a convolutional neural network (CNN) or logistic regression were constructed on the basis of clinical, morphological and deep learning (DL) features. The area under the curve (AUC), accuracy, sensitivity and specificity were calculated to evaluate the discriminating ability of the models. Results: The AUCs of Models A (clinical), B (morphological) and C (DL features from the CTA image) in the external validation set were 0.5706, 0.9665 and 0.8453, respectively. The AUCs of Model D (clinical and DL features), Model E (clinical and morphological features) and Model F (clinical, morphological and DL features) in the external validation set were 0.8395, 0.9597 and 0.9696, respectively. Conclusions: The CNN-based DLM, which integrates clinical, morphological and DL features, outperforms other models in predicting IA stability. The DLM has the potential to assess IA stability and support clinical decision-making.